Pro Share Advisors LLC Dbv Technologies S.A. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.75 - $21.85 $62,726 - $238,361	-10,909 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.81 - $24.58 $4,404 - $6,439	-262 Reduced 2.35%	10,909 $245,000
Q2 2018 Aug 13, 2018	BUY	$18.6 - $24.94 $3,441 - $4,613	185 Added 1.68%	11,171 $215,000
Q1 2018 May 14, 2018	SELL	$20.86 - $26.6 $36,379 - $46,390	-1,744 Reduced 13.7%	10,986 $253,000
Q4 2017 Feb 14, 2018	SELL	$20.9 - $49.36 $6,081 - $14,363	-291 Reduced 2.23%	12,730 $313,000
Q3 2017 Nov 13, 2017	BUY	$39.62 - $46.17 $20,008 - $23,315	505 Added 4.03%	13,021 $553,000
Q2 2017 Aug 11, 2017	BUY	N/A	12,516	12,516 $447,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $88.3M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.